Jack Nathan Medical Corp. (JNHMF)
| Previous close | 0.0750 |
| Open | 0.0750 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0750 - 0.0750 |
| 52-week range | 0.0350 - 0.2040 |
| Volume | |
| Avg. volume | 1,955 |
| Market cap | 6.325M |
| Beta (5Y monthly) | -1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0770 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Jack Nathan Health Announces Voting Results from Annual and Special Shareholders’ Meeting
TORONTO, December 28, 2022--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the "AGM") held on Friday, December 23, 2022 were approved. The AGM was originally called for December 2, 2022, but was adjourned until December 23, 2022 (see the Company’s press release dated December 2, 2022).
- Business Wire
Jack Nathan Health Announces Q3 Fiscal 2023 Financial Results
TORONTO, December 22, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the third quarter of fiscal 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
- Business Wire
Jack Nathan Health Provides Corporate Update
TORONTO, December 03, 2022--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") reports that it has adjourned its annual and special meeting of shareholders of the Company (the "AGM") until 1:30 p.m. (Toronto time) on Friday, December 23, 2022. The adjourned meeting will be held in person on December 23 (rather than via zoom and teleconference) at the offices of Dickinson Wright LLP, 199 Bay Street, Suite 2200, Commerce Court West, Toronto Ontario, Canada. The rescheduling of
